Go Pro
→ The $15 Gold Fund That Pays Up to $1,152/Month (From Investors Alley) (Ad)tc pixel Free ALXO Stock Alerts

ALX Oncology (ALXO) Institutional Ownership

ALX Oncology logo
$2.07 0.00 (0.00%)
Closing price 07/2/2026 04:00 PM Eastern
Extended Trading
$2.08 +0.01 (+0.24%)
As of 07/2/2026 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Institutional Ownership Changes (13F Filings) for ALX Oncology (NASDAQ:ALXO)

Current
Institutional Ownership
Percentage
97.97%
Number of
Institutional Buyers
(last 12 months)
13
Total
Institutional Inflows
(last 12 months)
$30.87M
Number of
Institutional Sellers
(last 12 months)
8
Total
Institutional Outflows
(last 12 months)
$1.87M
Get ALXO Insider Trade Alerts

Want to know when executives and insiders are buying or selling ALX Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

ALXO Institutional Buying and Selling by Quarter

ALX Oncology Major Shareholders & Ownership History

Export
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/20/2026Vivo Capital LLC3,184,713$6.39M0.5%N/A2.367%
5/19/2026Bank of America Corp DE577,783$1.16M0.0%+8.6%0.429%
5/18/2026Redmile Group LLC7,964,188$15.97M1.1%+143.9%5.919%
5/16/2026venBio Partners LLC12,884,638$25.83M9.2%+32.8%9.575%
5/16/2026Orbimed Advisors LLC2,866,256$5.75M0.1%N/A2.130%
5/15/2026OMERS ADMINISTRATION Corp75,000$150K0.0%N/A0.056%
5/14/2026Renaissance Technologies LLC732,599$1.47M0.0%+73.2%0.544%
2/26/2026Seven Fleet Capital Management LP117,817$133K0.1%N/A0.217%
2/18/2026Bridgeway Capital Management LLC76,072$86K0.0%+111.3%0.140%
2/13/2026Marshall Wace LLP26,376$30K0.0%-33.4%0.049%
2/13/2026State Street Corp124,228$140K0.0%+11.0%0.229%
2/12/2026Renaissance Technologies LLC423,099$478K0.0%+157.2%0.780%
1/1/2026JPMorgan Chase & Co.61,899$113K0.0%-29.9%0.114%
11/17/2025Qube Research & Technologies Ltd16,946$31K0.0%-61.6%0.031%
11/17/2025Bank of America Corp DE530,828$971K0.0%-48.7%0.979%
11/17/2025Ameriprise Financial Inc.652,897$1.20M0.0%N/A1.204%
11/14/2025Two Sigma Investments LP606,671$1.11M0.0%+26.9%1.119%
11/14/2025Bridgeway Capital Management LLC36,000$66K0.0%N/A0.066%
11/7/2025Vanguard Group Inc.1,528,619$2.80M0.0%-4.5%2.855%
11/7/2025JPMorgan Chase & Co.61,899$113K0.0%-29.9%0.116%
8/15/2025Bank of America Corp DE1,035,127$430K0.0%-28.7%1.933%
8/14/2025Jane Street Group LLC203,266$84K0.0%N/A0.381%
8/14/2025Redmile Group LLC3,391,455$1.41M0.1%-6.8%6.352%
8/13/2025Marshall Wace LLP106,280$45K0.0%-60.8%0.199%
8/12/2025XTX Topco Ltd74,770$31K0.0%-19.0%0.140%
8/12/2025JPMorgan Chase & Co.88,352$37K0.0%-75.3%0.165%
8/8/2025Geode Capital Management LLC315,421$131K0.0%-59.1%0.591%
6/27/2025Goldman Sachs Group Inc.373,214$233K0.0%-34.4%0.699%
5/21/2025Acadian Asset Management LLC1,296,331$806K0.0%+16.8%2.428%
5/16/2025Goldman Sachs Group Inc.373,214$233K0.0%-34.4%0.699%
5/16/2025AQR Capital Management LLC119,050$74K0.0%+183.6%0.223%
5/16/2025Almitas Capital LLC1,353,141$843K0.3%+10.6%2.534%
5/15/2025Redmile Group LLC3,640,834$2.27M0.2%-1.3%6.819%
5/15/2025MPM Bioimpact LLC550,000$343K0.1%-60.5%1.030%
5/12/2025Nuveen LLC164,790$103K0.0%N/A0.309%
5/12/2025Invesco Ltd.73,836$46K0.0%N/A0.138%
5/8/2025XTX Topco Ltd92,259$57K0.0%-65.0%0.173%
2/17/2025Two Sigma Investments LP704,131$1.18M0.0%+6.7%1.335%
2/17/2025Two Sigma Advisers LP823,900$1.38M0.0%+64.6%1.562%
2/17/2025Tang Capital Management LLC3,296,883$5.51M0.4%-21.6%6.251%
Do NOT Buy SpaceX – Do This Instead (Ad)

SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in could be a costly mistake. He calls it among the most overhyped, overvalued large-cap offerings ever pushed onto everyday investors. Tilson believes a rare economic event is approaching - one with serious consequences for your portfolio this summer. He has prepared a free analysis outlining what he sees and the specific steps he recommends taking now.tc pixel

Read Tilson's free analysis and find out what to do with your money
2/17/2025Redmile Group LLC3,689,611$6.16M0.4%-3.8%6.996%
2/17/2025MPM Bioimpact LLC1,391,434$2.32M0.3%-42.3%2.638%
2/17/2025Nuveen Asset Management LLC164,790$275K0.0%+55.6%0.312%
2/17/2025Deutsche Bank AG101,113$169K0.0%+521.0%0.192%
2/17/2025D. E. Shaw & Co. Inc.255,878$427K0.0%-11.9%0.485%
2/17/2025Cubist Systematic Strategies LLC32,021$53K0.0%-91.7%0.061%
2/17/2025Bridgeway Capital Management LLC75,000$125K0.0%N/A0.142%
2/17/2025Bank of America Corp DE1,035,326$1.73M0.0%+492.9%1.963%
2/17/2025Almitas Capital LLC1,222,945$2.04M0.4%N/A2.319%
2/14/2025Northern Trust Corp343,066$573K0.0%+7.3%0.650%
2/14/2025Dimensional Fund Advisors LP26,233$44K0.0%-30.3%0.050%
2/13/2025XTX Topco Ltd263,856$441K0.0%-16.8%0.500%
2/13/2025Bank of Nova Scotia105,306$176K0.0%N/A0.200%
2/13/2025Bank of Montreal Can826,582$1.38M0.0%N/A1.567%
2/12/2025Geode Capital Management LLC740,106$1.24M0.0%+5.6%1.403%
2/12/2025JPMorgan Chase & Co.236,046$394K0.0%+476.7%0.448%
2/11/2025Sei Investments Co.60,795$102K0.0%N/A0.115%
2/6/2025Charles Schwab Investment Management Inc.216,707$362K0.0%-3.8%0.411%
2/4/2025Los Angeles Capital Management LLC301,419$503K0.0%+16.9%0.572%
2/4/2025Bank of New York Mellon Corp90,003$150K0.0%+12.0%0.171%
1/29/2025JSF Financial LLC17,500$29K0.0%N/A0.033%
11/19/2024Barclays PLC59,502$107K0.0%+243.6%0.113%
11/15/2024Barclays PLC59,502$107K0.0%+243.6%0.113%
11/15/2024XTX Topco Ltd317,322$578K0.0%N/A0.602%
11/15/2024Jane Street Group LLC27,918$51K0.0%-64.3%0.053%
11/15/2024Wellington Management Group LLP167,831$305K0.0%+15.2%0.318%
11/15/2024State Street Corp671,376$1.22M0.0%-4.8%1.273%
11/15/2024Redmile Group LLC3,836,576$6.98M0.4%-5.0%7.274%
11/14/2024Verition Fund Management LLC133,025$242K0.0%+308.4%0.252%
11/14/2024Walleye Capital LLC230,875$420K0.0%+110.3%0.438%
11/13/2024FMR LLC5,865,106$10.67M0.0%-25.0%11.121%
11/12/2024Charles Schwab Investment Management Inc.225,302$410K0.0%-4.5%0.428%
11/8/2024Connor Clark & Lunn Investment Management Ltd.83,042$151K0.0%+207.4%0.158%
11/5/2024GSA Capital Partners LLP48,204$88K0.0%N/A0.092%
11/4/2024Los Angeles Capital Management LLC257,779$469K0.0%N/A0.489%
11/2/2024Privium Fund Management B.V.509,059$926K0.2%+28.2%0.967%
10/3/2024SG Americas Securities LLC27,394$50K0.0%+33.6%0.053%
8/19/2024Point72 Asset Management L.P.304,100$1.83M0.0%N/A0.584%
8/16/2024Algert Global LLC41,215$249K0.0%N/A0.079%
8/15/2024Susquehanna Portfolio Strategies LLC73,468$443K0.0%-19.2%0.141%
8/15/2024The Manufacturers Life Insurance Company13,662$82K0.0%-77.3%0.026%
8/15/2024AQR Capital Management LLC18,079$109K0.0%+50.7%0.035%
8/14/2024Cubist Systematic Strategies LLC199,441$1.20M0.0%N/A0.383%
8/14/2024Marshall Wace LLP635,679$3.83M0.0%+423.0%1.220%
8/12/2024Inspire Investing LLC58,707$354K0.0%+77.1%0.113%
8/12/2024Hsbc Holdings PLC10,780$63K0.0%N/A0.021%
8/9/2024Renaissance Technologies LLC438,200$2.64M0.0%+87.2%0.841%
8/9/2024Dimensional Fund Advisors LP34,543$208K0.0%-31.4%0.066%
8/8/2024American Century Companies Inc.23,685$143K0.0%-20.2%0.045%
8/6/2024Quest Partners LLC20,781$125K0.0%-17.0%0.040%
The REAL Reason Trump is Invading Iran (Ad)

For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.tc pixel

Click here to find out what it is.
8/1/2024Rhumbline Advisers55,220$333K0.0%+10.8%0.106%
8/1/2024Privium Fund Management B.V.396,966$2.27M0.6%N/A0.762%
7/29/2024Zurcher Kantonalbank Zurich Cantonalbank6,517$39K0.0%+394.8%0.013%
7/26/2024Bank of New York Mellon Corp104,966$633K0.0%+31.6%0.201%
7/12/2024SG Americas Securities LLC20,506$124K0.0%-14.2%0.039%
5/16/2024California State Teachers Retirement System22,797$254K0.0%+413.8%0.044%
5/16/2024Redmile Group LLC4,326,509$48.24M1.8%+18.2%8.304%
5/15/2024Price T Rowe Associates Inc. MD232,769$2.60M0.0%-57.2%0.447%
5/14/2024EntryPoint Capital LLC2,847$32K0.0%N/A0.005%
5/14/2024CANADA LIFE ASSURANCE Co2,379$27K0.0%N/A0.005%


ALXO Institutional Ownership - Frequently Asked Questions

During the previous two years, 60 institutional investors and hedge funds held shares of ALX Oncology. The most heavily invested institutionals were venBio Partners LLC ($25.83M), Redmile Group LLC ($15.97M), FMR LLC ($10.67M), Vivo Capital LLC ($6.39M), Orbimed Advisors LLC ($5.75M), Tang Capital Management LLC ($5.51M), and Vanguard Group Inc. ($2.80M).Learn more on ALX Oncology's institutional investors.

97.97% of ALX Oncology's stock is owned by institutional investors. Learn more on ALXO's institutional investor holdings.

Of the 47 institutional investors that purchased ALX Oncology's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Redmile Group LLC ($4.70M), venBio Partners LLC ($3.18M), Vivo Capital LLC ($3.18M), Orbimed Advisors LLC ($2.87M), Almitas Capital LLC ($1.35M), Bank of America Corp DE ($906.64K), and Bank of Montreal Can ($826.58K).

Institutional investors have bought a total of 15,815,279 shares in the last 24 months. This purchase volume represents approximately $30.87M in transactions.

The following institutional investors have sold ALX Oncology stock in the last 24 months: Bank of America Corp DE ($920.95K), Geode Capital Management LLC ($455.49K), JPMorgan Chase & Co. ($322.51K), Redmile Group LLC ($249.38K), Marshall Wace LLP ($178.12K), Vanguard Group Inc. ($72.19K), and Qube Research & Technologies Ltd ($27.19K).

Institutional investors have sold a total of 2,243,315 shares in the last 24 months. This volume of shares sold represents approximately $1.87M in transactions.


Related Companies

This page (NASDAQ:ALXO) was last updated on 7/5/2026 by MarketBeat.com Staff.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Do NOT Buy SpaceX – Do This Instead
SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...
Stansberry Research | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
Trump just signed it
A recent policy development is drawing attention from income-focused investors. According to one analyst, c...
Investors Alley | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
From the man who predicted 2008 crash…
Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...
Porter & Company | Sponsoredtc pixel